Involvement of the Microglial Aryl Hydrocarbon Receptor in Neuroinflammation and Vasogenic Edema after Ischemic Stroke.
Animals
Brain Edema
/ etiology
Brain Injuries
/ etiology
Cytochrome P-450 CYP1A1
/ metabolism
Cytokines
/ metabolism
Encephalitis
/ etiology
Humans
Indoleamine-Pyrrole 2,3,-Dioxygenase
/ metabolism
Infarction, Middle Cerebral Artery
/ complications
Ischemic Stroke
/ complications
Ligands
Macrophages
/ metabolism
Male
Mice, Inbred ICR
Microglia
/ metabolism
NADPH Oxidases
/ genetics
Oxidative Stress
Promoter Regions, Genetic
/ genetics
Protein Subunits
/ metabolism
Reactive Oxygen Species
/ metabolism
Receptors, Aryl Hydrocarbon
/ antagonists & inhibitors
THP-1 Cells
Tumor Necrosis Factor-alpha
/ metabolism
Up-Regulation
AhR
edema
inflammation
ischemia
p47phox
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
24 03 2021
24 03 2021
Historique:
received:
15
02
2021
revised:
19
03
2021
accepted:
22
03
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
1
2
2022
Statut:
epublish
Résumé
Microglia are activated after ischemic stroke and induce neuroinflammation. The expression of the aryl hydrocarbon receptor (AhR) has recently been reported to elicit cytokine expression. We previously reported that microglial activation mediates ischemic edema progression. Thus, the purpose of this study was to examine the role of AhR in inflammation and edema after ischemia using a mouse middle cerebral artery occlusion (MCAO) model. MCAO upregulated AhR expression in microglia during ischemia. MCAO increased the expression of tumor necrosis factor α (TNFα) and then induced edema progression, and worsened the modified neurological severity scores, with these being suppressed by administration of an AhR antagonist, CH223191. In THP-1 macrophages, the NADPH oxidase (NOX) subunit p47phox was significantly increased by AhR ligands, especially under inflammatory conditions. Suppression of NOX activity by apocynin or elimination of superoxide by superoxide dismutase decreased TNFα expression, which was induced by the AhR ligand. AhR ligands also elicited p47phox expression in mouse primary microglia. Thus, p47phox may be important in oxidative stress and subsequent inflammation. In MCAO model mice, P47phox expression was upregulated in microglia by ischemia. Lipid peroxidation induced by MCAO was suppressed by CH223191. Taken together, these findings suggest that AhR in the microglia is involved in neuroinflammation and subsequent edema, after MCAO via p47phox expression upregulation and oxidative stress.
Identifiants
pubmed: 33804845
pii: cells10040718
doi: 10.3390/cells10040718
pmc: PMC8063823
pii:
doi:
Substances chimiques
Cytokines
0
IDO1 protein, mouse
0
Indoleamine-Pyrrole 2,3,-Dioxygenase
0
Ligands
0
Protein Subunits
0
Reactive Oxygen Species
0
Receptors, Aryl Hydrocarbon
0
Tumor Necrosis Factor-alpha
0
Cytochrome P-450 CYP1A1
EC 1.14.14.1
NADPH Oxidases
EC 1.6.3.-
neutrophil cytosolic factor 1
EC 1.6.3.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIEHS NIH HHS
ID : R01 ES019898
Pays : United States
Organisme : Japan Society for the Promotion of Science
ID : 20H04341
Organisme : Japan Society for the Promotion of Science
ID : 17K08356
Organisme : NIEHS NIH HHS
ID : P30 ES023513
Pays : United States
Organisme : the Environment Research and Technology Development Fund
ID : JPMEERF20205007
Organisme : Japan Society for the Promotion of Science
ID : 17H04714
Organisme : NIEHS NIH HHS
ID : R01 ES029126
Pays : United States
Organisme : Japan Society for the Promotion of Science
ID : 15KK0024
Références
J Biol Chem. 2015 Sep 11;290(37):22805-17
pubmed: 26231211
Pharmacol Ther. 2018 Jul;187:71-87
pubmed: 29458109
Glia. 2015 Jul;63(7):1138-54
pubmed: 25690886
Int J Mol Sci. 2019 May 30;20(11):
pubmed: 31151139
Physiol Rev. 2007 Jan;87(1):245-313
pubmed: 17237347
Free Radic Biol Med. 2009 Sep 15;47(6):825-34
pubmed: 19559082
Biochem Biophys Res Commun. 2014 Aug 8;450(4):1553-9
pubmed: 25019995
Biochim Biophys Acta. 2012 Apr;1820(4):503-10
pubmed: 22306153
Circulation. 2014 Dec 2;130(23):2040-51
pubmed: 25359166
Neurosci Lett. 2019 Aug 24;708:134363
pubmed: 31276728
J Biol Chem. 2014 Jan 17;289(3):1866-75
pubmed: 24302727
Biochim Biophys Acta. 2003 Feb 17;1619(3):263-8
pubmed: 12573486
Expert Opin Drug Metab Toxicol. 2013 Feb;9(2):141-52
pubmed: 23230817
Biochem Biophys Res Commun. 1998 Jul 30;248(3):554-8
pubmed: 9703964
Neurochem Int. 2012 Jun;60(8):782-90
pubmed: 22449404
Toxicol Sci. 2004 Nov;82(1):297-307
pubmed: 15329440
Toxicol Appl Pharmacol. 2006 Jul 15;214(2):109-17
pubmed: 16430935
J Neuroinflammation. 2019 Oct 12;16(1):187
pubmed: 31606043
Sci Rep. 2017 Jul 24;7(1):6268
pubmed: 28740157
Cell Death Dis. 2013 Mar 07;4:e525
pubmed: 23470532
Neuroimmunomodulation. 2013;20(5):264-73
pubmed: 23867217
Biochem Biophys Res Commun. 2018 Feb 5;496(2):582-587
pubmed: 29353043
Toxicol Sci. 2019 Aug 1;170(2):404-414
pubmed: 31093659
J Neurosci Methods. 2011 Jan 15;194(2):287-96
pubmed: 21074565
Am J Physiol Cell Physiol. 2019 Feb 1;316(2):C135-C153
pubmed: 30379577
Cell Death Dis. 2019 Jun 20;10(7):487
pubmed: 31221990
Cancers (Basel). 2019 Apr 27;11(5):
pubmed: 31035533
Toxicol Lett. 2014 Jan 30;224(3):362-70
pubmed: 24231000
Nat Rev Drug Discov. 2019 May;18(5):379-401
pubmed: 30760888
Nucleic Acids Res. 1998 Jan 1;26(1):362-7
pubmed: 9399875
Mol Pharmacol. 1994 Nov;46(5):915-21
pubmed: 7969080
Biochem Biophys Res Commun. 2017 Aug 5;489(4):361-368
pubmed: 28479245
Biochem Biophys Res Commun. 2008 Oct 24;375(3):331-5
pubmed: 18694728
Stroke. 2001 Nov;32(11):2682-8
pubmed: 11692034
PLoS One. 2014 Jul 03;9(7):e101815
pubmed: 24992685
J Surg Res. 2002 May 15;104(2):118-23
pubmed: 12020130
Mol Brain. 2020 Apr 7;13(1):57
pubmed: 32264906
Sci Rep. 2020 Sep 10;10(1):14906
pubmed: 32913241
Cell. 2008 Feb 8;132(3):344-62
pubmed: 18267068
Brain Res. 2015 May 22;1608:225-34
pubmed: 25770058
Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):43-51
pubmed: 15993909
J Neurosci Methods. 2015 Jul 15;249:99-105
pubmed: 25936850